Ignite Creation Date:
2025-12-25 @ 2:05 AM
Ignite Modification Date:
2026-06-07 @ 5:36 PM
Study NCT ID:
NCT06184360
Status:
COMPLETED
Last Update Posted:
2023-12-28
First Post:
2023-12-14
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world Evaluation of BEOVU (Brolucizumab) Effectiveness and Durability for Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD)
Sponsor:
Novartis Pharmaceuticals
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
CRTH258A2014
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None